BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 2006;55:342-7. [PMID: 16000642 DOI: 10.1136/gut.2005.065557] [Cited by in Crossref: 227] [Cited by in F6Publishing: 227] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 2013;11:1075-83. [PMID: 23851019 DOI: 10.1016/j.cgh.2013.07.001] [Cited by in Crossref: 170] [Cited by in F6Publishing: 165] [Article Influence: 18.9] [Reference Citation Analysis]
2 Liu X, Xu J, Mei Q, Han L, Huang J. Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice. Dig Dis Sci. 2013;58:107-114. [PMID: 22777616 DOI: 10.1007/s10620-012-2304-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
3 Noth R, Stüber E, Häsler R, Nikolaus S, Kühbacher T, Hampe J, Bewig B, Schreiber S, Arlt A. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease. Journal of Crohn's and Colitis 2012;6:464-9. [DOI: 10.1016/j.crohns.2011.10.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
4 Seiderer J, Brand S, Herrmann KA, Schnitzler F, Hatz R, Crispin A, Pfennig S, Schoenberg SO, Göke B, Lohse P, Ochsenkühn T. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohnʼs disease in clinical practice: Results of a Prospective Study: . Inflammatory Bowel Diseases 2006;12:1114-21. [DOI: 10.1097/01.mib.0000235836.32176.5e] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
5 Dessein R, Rosenstiel P, Chamaillard M. Debugging the intestinal microbiota in IBD. Gastroenterol Clin Biol 2009;33 Suppl 3:S131-6. [PMID: 20117336 DOI: 10.1016/S0399-8320(09)73148-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Cotton JA, Amat CB, Buret AG. Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastro-Intestinal Tract. Pathogens 2015;4:764-92. [PMID: 26569316 DOI: 10.3390/pathogens4040764] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
7 Norman K, Pirlich M, Schulzke JD, Smoliner C, Lochs H, Valentini L, Bühner S. Increased intestinal permeability in malnourished patients with liver cirrhosis. Eur J Clin Nutr. 2012;66:1116-1119. [PMID: 22872031 DOI: 10.1038/ejcn.2012.104] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
8 Michielan A, D’Incà R. Host-microbiome interaction in Crohn’s disease: A familiar or familial issue? World J Gastrointest Pathophysiol 2015; 6(4): 159-168 [PMID: 26600974 DOI: 10.4291/wjgp.v6.i4.159] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
9 Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1000-1011. [PMID: 18452220 DOI: 10.1002/ibd.20480] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 6.4] [Reference Citation Analysis]
10 Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol. 2007;50:1561-1569. [PMID: 17936155 DOI: 10.1016/j.jacc.2007.07.016] [Cited by in Crossref: 302] [Cited by in F6Publishing: 268] [Article Influence: 20.1] [Reference Citation Analysis]
11 Citalán-Madrid AF, Vargas-Robles H, García-Ponce A, Shibayama M, Betanzos A, Nava P, Salinas-Lara C, Rottner K, Mennigen R, Schnoor M. Cortactin deficiency causes increased RhoA/ROCK1-dependent actomyosin contractility, intestinal epithelial barrier dysfunction, and disproportionately severe DSS-induced colitis. Mucosal Immunol 2017;10:1237-47. [PMID: 28120846 DOI: 10.1038/mi.2016.136] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
12 Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. [PMID: 26582965 DOI: 10.1155/2015/628157] [Cited by in Crossref: 221] [Cited by in F6Publishing: 212] [Article Influence: 31.6] [Reference Citation Analysis]
13 He F, Peng J, Deng XL, Yang LF, Camara AD, Omran A, Wang GL, Wu LW, Zhang CL, Yin F. Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier. Cytokine. 2012;59:264-272. [PMID: 22583690 DOI: 10.1016/j.cyto.2012.04.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
14 Vogelsang H. Do changes in intestinal permeability predict disease relapse in Crohn's disease? Inflamm Bowel Dis. 2008;14 Suppl 2:S162-S163. [PMID: 18816766 DOI: 10.1002/ibd.20617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
15 Ragnarsson EGE, Schoultz I, Gullberg E, Carlsson AH, Tafazoli F, Lerm M, Magnusson K, Söderholm JD, Artursson P. Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasin-dependent macropinocytosis. Lab Invest 2008;88:1215-26. [DOI: 10.1038/labinvest.2008.86] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
16 Wei SC, Yang-Yen HF, Tsao PN, Weng MT, Tung CC, Yu LCH, Lai LC, Hsiao JH, Chuang EY, Shun CT, Ni YH, Xavier RJ, Podolsky DK, Yen JJY, Wong JM. SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway. Inflamm Bowel Dis 2017;23:1730-40. [PMID: 28906292 DOI: 10.1097/MIB.0000000000001250] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Muehler A, Slizgi JR, Kohlhof H, Groeppel M, Peelen E, Vitt D. Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases. World J Gastrointest Pathophysiol 2020; 11(6): 114-130 [PMID: 33362939 DOI: 10.4291/wjgp.v11.i6.114] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Teshima CW, Goodman KJ, El-kalla M, Turk S, El-matary W, Valcheva R, Danchak R, Gordon M, Ho P, Mullins A, Wong D, Kao D, Meddings J, Huynh H, Dieleman LA. Increased Intestinal Permeability in Relatives of Patients With Crohn’s Disease Is Not Associated With Small Bowel Ulcerations. Clinical Gastroenterology and Hepatology 2017;15:1413-1418.e1. [DOI: 10.1016/j.cgh.2017.02.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
19 Büning C, Geissler N, Prager M, Sturm A, Baumgart DC, Büttner J, Bühner S, Haas V, Lochs H. Increased small intestinal permeability in ulcerative colitis: Rather genetic than environmental and a risk factor for extensive disease?: . Inflammatory Bowel Diseases 2012;18:1932-9. [DOI: 10.1002/ibd.22909] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
20 Hering NA, Fromm M, Schulzke JD. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol. 2012;590:1035-1044. [PMID: 22219336 DOI: 10.1113/jphysiol.2011.224568] [Cited by in Crossref: 159] [Cited by in F6Publishing: 153] [Article Influence: 15.9] [Reference Citation Analysis]
21 Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007;23:379-383. [PMID: 17545772 DOI: 10.1097/mog.0b013e32816aa392] [Cited by in Crossref: 207] [Cited by in F6Publishing: 107] [Article Influence: 13.8] [Reference Citation Analysis]
22 Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res 2020;9:F1000 Faculty Rev-69. [PMID: 32051759 DOI: 10.12688/f1000research.20510.1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 27.5] [Reference Citation Analysis]
23 Lin Y, Li B, Yang X, Liu T, Shi T, Deng B, Zhang Y, Jia L, Jiang Z, He R. Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis. Mucosal Immunol 2019;12:1304-15. [PMID: 31534167 DOI: 10.1038/s41385-019-0204-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
24 Kelsall B. Innate and adaptive mechanisms to control of pathological intestinal inflammation. J Pathol 2008;214:242-59. [DOI: 10.1002/path.2286] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
25 Bamias G, Cominelli F. Exploring the Early Phase of Crohn's Disease. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31283-0. [PMID: 32949730 DOI: 10.1016/j.cgh.2020.09.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Al Nabhani Z, Berrebi D, Martinez-Vinson C, Montcuquet N, Madre C, Roy M, Ogier-Denis E, Dussaillant M, Cerf-Bensussan N, Zouali H, Daniel F, Barreau F, Hugot JP. Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine. J Crohns Colitis 2020;14:669-79. [PMID: 31784737 DOI: 10.1093/ecco-jcc/jjz196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Schreiber S. Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health. Gut 2006;55:308-9. [PMID: 16474103 DOI: 10.1136/gut.2005.076075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
28 Forteza R, Figueroa Y, Mashukova A, Dulam V, Salas PJ. Conditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB. Mol Biol Cell 2016;27:2186-97. [PMID: 27226486 DOI: 10.1091/mbc.E16-02-0086] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Rashid T, Ebringer A, Tiwana H, Fielder M. Role of Klebsiella and collagens in Crohn’s disease: a new prospect in the use of low-starch diet. Eur J Gastroenterol Hepatol. 2009;21:843-849. [PMID: 19352192 DOI: 10.1097/meg.0b013e328318ecde] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
30 Büning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, Bühner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JPH, Landt O, Nickel R, Büttner J, Lochs H, Witt H. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn’s disease but also ulcerative colitis: IL23R p.Arg381Gln IN IBD. Alimentary Pharmacology & Therapeutics 2007;26:1025-33. [DOI: 10.1111/j.1365-2036.2007.03446.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
31 Schulzke JD, Günzel D, John LJ, Fromm M. Perspectives on tight junction research. Ann N Y Acad Sci 2012;1257:1-19. [PMID: 22671584 DOI: 10.1111/j.1749-6632.2012.06485.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
32 Atreya I, Neurath MF. Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications. Expert Review of Gastroenterology & Hepatology 2014;2:23-34. [DOI: 10.1586/17474124.2.1.23] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
33 Münch A, Söderholm JD, Ost A, Ström M. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol. 2009;104:679-685. [PMID: 19209166 DOI: 10.1038/ajg.2008.95] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
34 Jo H, Hwang D, Kim JK, Lim YH. Oxyresveratrol improves tight junction integrity through the PKC and MAPK signaling pathways in Caco-2 cells. Food Chem Toxicol 2017;108:203-13. [PMID: 28780155 DOI: 10.1016/j.fct.2017.08.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
35 Papp M, Foldi I, Altorjay I, Palyu E, Udvardy M, Tumpek J, Sipka S, Korponay-Szabo IR, Nemes E, Veres G, Dinya T, Tordai A, Andrikovics H, Norman GL, Lakatos PL. Anti-microbial antibodies in celiac disease: Trick or treat? World J Gastroenterol 2009; 15(31): 3891-3900 [PMID: 19701969 DOI: 10.3748/wjg.15.3891] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
36 Gan J, Nazarian S, Teare J, Darzi A, Ashrafian H, Thompson AJ. A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn's disease. BMC Gastroenterol 2022;22:16. [PMID: 35012471 DOI: 10.1186/s12876-021-02082-z] [Reference Citation Analysis]
37 Jeong SY, Im YN, Youm JY, Lee HK, Im SY. l-Glutamine Attenuates DSS-Induced Colitis via Induction of MAPK Phosphatase-1. Nutrients 2018;10:E288. [PMID: 29494494 DOI: 10.3390/nu10030288] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
38 Olbe L. Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease. Scandinavian Journal of Gastroenterology 2009;43:234-41. [DOI: 10.1080/00365520701676971] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
39 Henderson P, van Limbergen JE, Schwarze J, Wilson DC. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:382-95. [PMID: 20645321 DOI: 10.1002/ibd.21379] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 7.9] [Reference Citation Analysis]
40 Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017;11:821-834. [PMID: 28650209 DOI: 10.1080/17474124.2017.1343143] [Cited by in Crossref: 234] [Cited by in F6Publishing: 209] [Article Influence: 46.8] [Reference Citation Analysis]
41 Ryu H, Posca D, Barrett T. Bin1: a new player in IBD barrier dysfunction. Dig Dis Sci 2012;57:1751-3. [PMID: 22644742 DOI: 10.1007/s10620-012-2228-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2020;22:E362. [PMID: 33396382 DOI: 10.3390/ijms22010362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
43 Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L, Fischer S, Osztovits J, Gemela O, Veres G. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer. 2007;7:54. [PMID: 17389035 DOI: 10.1186/1471-2407-7-54] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
44 Arseneau KO, Tamagawa H, Pizarro TT, Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep. 2007;9:508-512. [PMID: 18377804 DOI: 10.1007/s11894-007-0067-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
45 Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Färkkilä M, Kontula K. Family and twin studies in inflammatory bowel disease. World J Gastroenterol 2006; 12(23): 3668-3672 [PMID: 16773682 DOI: 10.3748/wjg.v12.i23.3668] [Cited by in CrossRef: 168] [Cited by in F6Publishing: 144] [Article Influence: 10.5] [Reference Citation Analysis]
46 Edelblum KL, Turner JR. Epithelial Cells. Mucosal Immunology. Elsevier; 2015. pp. 187-210. [DOI: 10.1016/b978-0-12-415847-4.00012-4] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
47 Amendola A, Butera A, Sanchez M, Strober W, Boirivant M. Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms. Mucosal Immunol. 2014;7:391-404. [PMID: 23962873 DOI: 10.1038/mi.2013.58] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
48 Qiu HJ, Wu W, Liu ZJ. Role of hypoxic injury in pathophysiology of intestinal mucosal inflammation. Shijie Huaren Xiaohua Zazhi 2013; 21(7): 591-596 [DOI: 10.11569/wcjd.v21.i7.591] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Chelakkot C, Ghim J, Rajasekaran N, Choi JS, Kim JH, Jang MH, Shin YK, Suh PG, Ryu SH. Intestinal Epithelial Cell-Specific Deletion of PLD2 Alleviates DSS-Induced Colitis by Regulating Occludin. Sci Rep 2017;7:1573. [PMID: 28484281 DOI: 10.1038/s41598-017-01797-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
50 Zimmerman NP, Kumar SN, Turner JR, Dwinell MB. Cyclic AMP dysregulates intestinal epithelial cell restitution through PKA and RhoA. Inflamm Bowel Dis 2012;18:1081-91. [PMID: 21993975 DOI: 10.1002/ibd.21898] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
51 Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci. 2012;1258:34-42. [PMID: 22731713 DOI: 10.1111/j.1749-6632.2012.06526.x] [Cited by in Crossref: 183] [Cited by in F6Publishing: 178] [Article Influence: 18.3] [Reference Citation Analysis]
52 Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016;9:606-625. [PMID: 27366227 DOI: 10.1177/1756283x16644242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 14.8] [Reference Citation Analysis]
53 Zhou F, Xia B, Wang F, Shrestha UK, Chen M, Wang H, Shi X, Chen Z, Li J. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China. Clin Chim Acta. 2010;411:1461-1465. [PMID: 20570669 DOI: 10.1016/j.cca.2010.05.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
54 Leech B, Schloss J, Steel A. Investigation into complementary and integrative medicine practitioners' clinical experience of intestinal permeability: A cross-sectional survey. Complementary Therapies in Clinical Practice 2018;31:200-9. [DOI: 10.1016/j.ctcp.2018.02.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
55 Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schröder JM, Feingold KR, Elias PM. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008;128:917-25. [PMID: 17943185 DOI: 10.1038/sj.jid.5701099] [Cited by in Crossref: 168] [Cited by in F6Publishing: 149] [Article Influence: 11.2] [Reference Citation Analysis]
56 Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520. [PMID: 16966705 DOI: 10.1136/gut. 2005.085373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Trussoni CE, Tabibian JH, Splinter PL, O'Hara SP. Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR). PLoS One 2015;10:e0125793. [PMID: 25915403 DOI: 10.1371/journal.pone.0125793] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
58 Stewart AS, Pratt-Phillips S, Gonzalez LM. Alterations in Intestinal Permeability: The Role of the "Leaky Gut" in Health and Disease. J Equine Vet Sci 2017;52:10-22. [PMID: 31000910 DOI: 10.1016/j.jevs.2017.02.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
59 Hollander D. Intestinal Permeability Barrier in Crohn’s Disease: The Difficulty in Shifting the Paradigm. Dig Dis Sci 2013;58:1827-9. [DOI: 10.1007/s10620-013-2721-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
60 McCole DF. IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis. 2014;20:1829-1849. [PMID: 25215613 DOI: 10.1097/mib.0000000000000090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
61 Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M. IBD serological panels: facts and perspectives. Inflamm Bowel Dis. 2007;13:1561-1566. [PMID: 17636565 DOI: 10.1002/ibd.20226] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
62 Wolters VM, Xu W, Zhao X, Walters TD, Griffiths AM, Silverberg MS, Muise AM. Replication of genetic variation in the MYO9B gene in Crohn's disease. Hum Immunol 2011;72:592-7. [PMID: 21515326 DOI: 10.1016/j.humimm.2011.03.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
63 Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434. [PMID: 17653185 DOI: 10.1038/nature06005] [Cited by in Crossref: 2640] [Cited by in F6Publishing: 2548] [Article Influence: 176.0] [Reference Citation Analysis]
64 Blesl A, Stadlbauer V. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021;13:1018. [PMID: 33801133 DOI: 10.3390/nu13031018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Valentini L, Ramminger S, Haas V, Postrach E, Werich M, Fischer A, Koller M, Swidsinski A, Bereswill S, Lochs H, Schulzke JD. Small intestinal permeability in older adults. Physiol Rep 2014;2:e00281. [PMID: 24771689 DOI: 10.14814/phy2.281] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
66 Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis. 2009;27:443-449. [PMID: 19897958 DOI: 10.1159/000233282] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 6.3] [Reference Citation Analysis]
67 Eftychi C, Schwarzer R, Vlantis K, Wachsmuth L, Basic M, Wagle P, Neurath MF, Becker C, Bleich A, Pasparakis M. Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment. Immunity 2019;51:367-380.e4. [PMID: 31350179 DOI: 10.1016/j.immuni.2019.06.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
68 Wasilewska J, Klukowski M. Gastrointestinal symptoms and autism spectrum disorder: links and risks - a possible new overlap syndrome. Pediatric Health Med Ther 2015;6:153-66. [PMID: 29388597 DOI: 10.2147/PHMT.S85717] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 6.9] [Reference Citation Analysis]
69 Zuo L, Kuo WT, Turner JR. Tight Junctions as Targets and Effectors of Mucosal Immune Homeostasis. Cell Mol Gastroenterol Hepatol 2020;10:327-40. [PMID: 32304780 DOI: 10.1016/j.jcmgh.2020.04.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
70 van Lierop PP, Samsom JN, Escher JC, Nieuwenhuis EE. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:142-151. [PMID: 19179875 DOI: 10.1097/mpg.0b013e3181821964] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
71 Prager M, Durmus T, Büttner J, Molnar T, de Jong DJ, Drenth JP, Baumgart DC, Sturm A, Farkas K, Witt H, Büning C. Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn’s disease. Scandinavian Journal of Gastroenterology 2014;49:1191-200. [DOI: 10.3109/00365521.2014.928903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
72 Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94:155-165. [PMID: 30611442 DOI: 10.1016/j.mayocp.2018.09.013] [Cited by in Crossref: 141] [Cited by in F6Publishing: 131] [Article Influence: 47.0] [Reference Citation Analysis]
73 Siminovitch KA. Advances in the molecular dissection of inflammatory bowel disease. Semin Immunol. 2006;18:244-253. [PMID: 16679026 DOI: 10.1016/j.smim.2006.03.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
74 van der Velden WJFM, Blijlevens NMA, Maas FMHM, Schaap NPM, Jansen JH, van der Reijden BA, Feuth T, Dolstra H, Donnelly JP. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplant 2009;44:243-8. [DOI: 10.1038/bmt.2009.21] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
75 Muise A, Rotin D. Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene. Expert Review of Molecular Diagnostics 2014;8:465-77. [DOI: 10.1586/14737159.8.4.465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
76 Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016;4:e1251384. [PMID: 28123927 DOI: 10.1080/21688370.2016.1251384] [Cited by in Crossref: 136] [Cited by in F6Publishing: 116] [Article Influence: 22.7] [Reference Citation Analysis]
77 Edelblum KL, Turner JR. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol. 2009;9:715-720. [PMID: 19632896 DOI: 10.1016/j.coph.2009.06.022] [Cited by in Crossref: 164] [Cited by in F6Publishing: 154] [Article Influence: 12.6] [Reference Citation Analysis]
78 Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut. 2013;62:1653-1664. [PMID: 24104886 DOI: 10.1136/gutjnl-2012-303955] [Cited by in Crossref: 195] [Cited by in F6Publishing: 192] [Article Influence: 21.7] [Reference Citation Analysis]
79 Prager M, Buettner J, Buening C. Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis. J Dig Dis. 2015;16:713-722. [PMID: 26512799 DOI: 10.1111/1751-2980.12296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
80 Bai AP. Intestinal barrier injury in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2008; 16(28): 3187-3191 [DOI: 10.11569/wcjd.v16.i28.3187] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
81 Hagbom M, De Faria FM, Winberg ME, Westerberg S, Nordgren J, Sharma S, Keita ÅV, Loitto V, Magnusson KE, Svensson L. Neurotrophic Factors Protect the Intestinal Barrier from Rotavirus Insult in Mice. mBio 2020;11:e02834-19. [PMID: 31964731 DOI: 10.1128/mBio.02834-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
82 Magro F, Portela F. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. BioDrugs. 2010;24 Suppl 1:3-14. [PMID: 21175228 DOI: 10.2165/11586290-000000000-00000] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
83 Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 2008; 14(33): 5115-5124 [PMID: 18777587 DOI: 10.3748/wjg.14.5115] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
84 Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1165-1179 [PMID: 24574793 DOI: 10.3748/wjg.v20.i5.1165] [Cited by in CrossRef: 169] [Cited by in F6Publishing: 149] [Article Influence: 21.1] [Reference Citation Analysis]
85 Sydora BC, Tavernini MM, Doyle J, Fedorak RN. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-α gene-deficient mice: . Inflammatory Bowel Diseases 2006;12:750-7. [DOI: 10.1097/00054725-200608000-00012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
86 Su L, Turner JR. Got Guts? Need Nerve! Gastroenterology 2007;132:1615-8. [DOI: 10.1053/j.gastro.2007.03.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Speir M, Djajawi TM, Conos SA, Tye H, Lawlor KE. Targeting RIP Kinases in Chronic Inflammatory Disease. Biomolecules 2021;11:646. [PMID: 33924766 DOI: 10.3390/biom11050646] [Reference Citation Analysis]
88 Sun X, Du M, Navarre DA, Zhu MJ. Purple Potato Extract Promotes Intestinal Epithelial Differentiation and Barrier Function by Activating AMP-Activated Protein Kinase. Mol Nutr Food Res 2018;62. [PMID: 29193691 DOI: 10.1002/mnfr.201700536] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
89 Martini E, Krug SM, Siegmund B, Neurath MF, Becker C. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2017;4:33-46. [PMID: 28560287 DOI: 10.1016/j.jcmgh.2017.03.007] [Cited by in Crossref: 173] [Cited by in F6Publishing: 174] [Article Influence: 34.6] [Reference Citation Analysis]
90 Grube M, Brenmoehl J, Rogler G, Hahn J, Herr W, Holler E. Donor Nucleotide-Binding Oligomerization–Containing Protein 2 (NOD2) Single Nucleotide Polymorphism 13 Is Associated with Septic Shock after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2015;21:1399-404. [DOI: 10.1016/j.bbmt.2015.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
91 Power N, Turpin W, Espin-Garcia O, Smith MI, Croitoru K; CCC GEM Project Research Consortium. Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients. Front Physiol 2021;12:645303. [PMID: 33841181 DOI: 10.3389/fphys.2021.645303] [Reference Citation Analysis]
92 Leech B, Schloss J, Steel A. Treatment Interventions for the Management of Intestinal Permeability: A Cross-Sectional Survey of Complementary and Integrative Medicine Practitioners. J Altern Complement Med 2019;25:623-36. [PMID: 31038350 DOI: 10.1089/acm.2018.0374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516-1526. [PMID: 31076401 DOI: 10.1136/gutjnl-2019-318427] [Cited by in Crossref: 151] [Cited by in F6Publishing: 144] [Article Influence: 50.3] [Reference Citation Analysis]
94 Robertson SJ, Rubino SJ, Geddes K, Philpott DJ. Examining host–microbial interactions through the lens of NOD: From plants to mammals. Seminars in Immunology 2012;24:9-16. [DOI: 10.1016/j.smim.2012.01.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
95 Borisova MA, Achasova KM, Morozova KN, Andreyeva EN, Litvinova EA, Ogienko AA, Morozova MV, Berkaeva MB, Kiseleva E, Kozhevnikova EN. Mucin-2 knockout is a model of intercellular junction defects, mitochondrial damage and ATP depletion in the intestinal epithelium. Sci Rep 2020;10:21135. [PMID: 33273633 DOI: 10.1038/s41598-020-78141-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Ronaghan NJ, Shang J, Iablokov V, Zaheer R, Colarusso P, Dion S, Désilets A, Leduc R, Turner JR, MacNaughton WK. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol 2016;311:G466-79. [PMID: 27492333 DOI: 10.1152/ajpgi.00441.2015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
97 Nylund CM, D'mello S, Kim M, Bonkowski E, Däbritz J, Foell D, Meddings J, Trapnell BC, Denson LA. Granulocyte Macrophage-Colony-stimulating Factor Autoantibodies and Increased Intestinal Permeability in Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 2011;52:542-8. [DOI: 10.1097/mpg.0b013e3181fe2d93] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
98 Prager M, Büttner J, Grunert P, Ellinghaus D, Büning C. A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease. Inflamm Bowel Dis 2016;22:2356-68. [PMID: 27598741 DOI: 10.1097/MIB.0000000000000910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
99 Nalle SC, Turner JR. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol 2015;8:720-30. [PMID: 25943273 DOI: 10.1038/mi.2015.40] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 10.1] [Reference Citation Analysis]
100 Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C, Ahrens R, Seidu L, McKenzie A, Strait R, Finkelman FD, Foster PS, Matthaei KI, Rothenberg ME, Hogan SP. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008;205:897-913. [PMID: 18378796 DOI: 10.1084/jem.20071046] [Cited by in Crossref: 195] [Cited by in F6Publishing: 184] [Article Influence: 13.9] [Reference Citation Analysis]
101 Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564-577. [PMID: 20622892 DOI: 10.1038/nrmicro2403] [Cited by in Crossref: 223] [Cited by in F6Publishing: 226] [Article Influence: 18.6] [Reference Citation Analysis]
102 Gaspar SR, Mendonça T, Oliveira P, Oliveira T, Dias J, Lopes T. Urolithiasis and crohn's disease. Urol Ann 2016;8:297-304. [PMID: 27453651 DOI: 10.4103/0974-7796.184879] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
103 Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Taylor K, Prescott NJ, Murrells T, Stagg AJ, Whelan K. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn’s disease and their unaffected siblings. Gut. 2014;63:1578-1586. [PMID: 24398881 DOI: 10.1136/gutjnl-2013-306226] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 10.1] [Reference Citation Analysis]
104 Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M, Foligne B, Ollendorff V, Heyman M, Bonacorsi S. CARD15/NOD2 is required for Peyer’s patches homeostasis in mice. PLoS One. 2007;2:e523. [PMID: 17565376 DOI: 10.1371/journal.pone.0000523] [Cited by in Crossref: 109] [Cited by in F6Publishing: 101] [Article Influence: 7.3] [Reference Citation Analysis]
105 Latiano A, Palmieri O, Valvano MR, D’Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2008;27:241-248. [PMID: 17944996 DOI: 10.1111/j.1365-2036.2007.03551.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
106 Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci. 2007;52:2015-2021. [PMID: 17404859 DOI: 10.1007/s10620-006-9622-2] [Cited by in Crossref: 357] [Cited by in F6Publishing: 336] [Article Influence: 23.8] [Reference Citation Analysis]
107 Romanos J, Rybak A, Wijmenga C, Wapenaar MC. Molecular diagnosis of celiac disease: are we there yet? Expert Opin Med Diagn 2008;2:399-416. [PMID: 23495707 DOI: 10.1517/17530059.2.4.399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
108 Rogler G. The effects of NOD2/CARD15 mutations on the function of the intestinal barrier. J Crohns Colitis. 2007;1:53-60. [PMID: 21172185 DOI: 10.1016/j.crohns.2007.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
109 Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases: . Inflammatory Bowel Diseases 2011;17:362-81. [DOI: 10.1002/ibd.21403] [Cited by in Crossref: 296] [Cited by in F6Publishing: 297] [Article Influence: 26.9] [Reference Citation Analysis]
110 Sun X, Zhu MJ. AMP-activated protein kinase: a therapeutic target in intestinal diseases. Open Biol 2017;7:170104. [PMID: 28835570 DOI: 10.1098/rsob.170104] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
111 Klil-Drori AJ, Tascilar K, Yin H, Aprikian A, Bitton A, Azoulay L. Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer. Am J Epidemiol 2016;184:15-22. [PMID: 27268031 DOI: 10.1093/aje/kwv307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
112 Xie Q, Gan HT. Controversies about the use of serological markers in diagnosis of inflammatory bowel disease. World J Gastroenterol 2010; 16(2): 279-280 [PMID: 20066751 DOI: 10.3748/wjg.v16.i2.279] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
113 Teshima CW, Meddings JB. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 2008;10:443-9. [PMID: 18799118 DOI: 10.1007/s11894-008-0083-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
114 Zhang Y, Li X, Li Y, Li Y, Wang Y, Zhu L, Chen P, Tian Z, Qiu Y, Feng R, Zeng Z, He Y, Chen B, Zhang S, Mao R, Chen M. DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease. Dig Dis Sci 2020. [PMID: 33184797 DOI: 10.1007/s10620-020-06697-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
115 Xu LF, Teng X, Guo J, Sun M. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation. 2012;35:308-315. [PMID: 21452036 DOI: 10.1007/s10753-011-9320-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
116 Veluswamy H, Suryawala K, Sheth A, Wells S, Salvatierra E, Cromer W, Chaitanya GV, Painter A, Patel M, Manas K. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol. 2010;10:104. [PMID: 20828408 DOI: 10.1186/1471-230x-10-104] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
117 Martín MC, Martinez A, Mendoza JL, Taxonera C, Díaz-Rubio M, Fernández-Arquero M, de la Concha EG, Urcelay E. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics. 2007;59:833-837. [PMID: 17955236 DOI: 10.1007/s00251-007-0255-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
118 Guzy C, Paclik D, Schirbel A, Sonnenborn U, Wiedenmann B, Sturm A. The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways. Int Immunol 2008;20:829-40. [PMID: 18448456 DOI: 10.1093/intimm/dxn041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
119 Nunes T, Fiorino G, Danese S, Sans M. Familial aggregation in inflammatory bowel disease: Is it genes or environment? World J Gastroenterol 2011; 17(22): 2715-2722 [PMID: 21734779 DOI: 10.3748/wjg.v17.i22.2715] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
120 Toutounji M, Wanes D, El-Harakeh M, El-Sabban M, Rizk S, Naim HY. Dextran Sodium Sulfate-Induced Impairment of Protein Trafficking and Alterations in Membrane Composition in Intestinal Caco-2 Cell Line. Int J Mol Sci 2020;21:E2726. [PMID: 32326391 DOI: 10.3390/ijms21082726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
121 Cortez RV, Moreira LN, Padilha M, Bibas MD, Toma RK, Porta G, Taddei CR. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Front Immunol 2020;11:598152. [PMID: 33613519 DOI: 10.3389/fimmu.2020.598152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
122 Keita ÅV, Lindqvist CM, Öst Å, Magana CDL, Schoultz I, Halfvarson J. Gut Barrier Dysfunction-A Primary Defect in Twins with Crohn's Disease Predominantly Caused by Genetic Predisposition. J Crohns Colitis 2018;12:1200-9. [PMID: 29659773 DOI: 10.1093/ecco-jcc/jjy045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
123 Turpin W, Espin-garcia O, Bedrani L, Madsen K, Meddings JB, Raygoza Garay JA, Silverberg MS, Smith MI, Griffiths AM, Moayyedi P, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Turner D, Walters T, Paterson AD, Abreu M, Beck P, Bernstein C, Croitoru K, Dieleman L, Feagan B, Griffiths A, Guttman D, Jacobson K, Kaplan G, Krause DO, Madsen K, Marshall J, Moayyedi P, Ropeleski M, Seidman E, Silverberg M, Snapper S, Stadnyk A, Steinhart H, Surette M, Turner D, Walters T, Vallance B, Aumais G, Bitton A, Cino M, Critch J, Denson L, Deslandres C, El-matary W, Herfarth H, Higgins P, Huynh H, Hyams J, Mack D, Mcgrath J, Cvitkovitch D, Otley A, Panancionne R, Bernstein C, Deslandres C, Leddin D, Daly D, Saibil F, Aumais G, Huynh H, Brill H, Steinhart H, Wrobel I, Critch J, Hyams J, Jones J, Mcgrath J, Dieleman L, Cino M, Dirks M, Leleiko N, Pare P, Panancionne R, Silverberg MS, Griffiths AM, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Walters T, Xu W, Croitoru K; CCC GEM Project Research Consortium. Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn’s Disease. Inflammatory Bowel Diseases 2019;25:1796-804. [DOI: 10.1093/ibd/izz116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
124 Dessein R, Chamaillard M, Danese S. Innate immunity in Crohn's disease: the reverse side of the medal. J Clin Gastroenterol 2008;42 Suppl 3 Pt 1:S144-7. [PMID: 18806708 DOI: 10.1097/MCG.0b013e3181662c90] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
125 Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF. Crohn’s disease: beyond antagonists of tumour necrosis factor. Lancet. 2008;372:67-81. [PMID: 18603161 DOI: 10.1016/s0140-6736(08)60995-2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
126 Savidge TC, Newman P, Pothoulakis C, Ruhl A, Neunlist M, Bourreille A, Hurst R, Sofroniew MV. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology. 2007;132:1344-1358. [PMID: 17408650 DOI: 10.1053/j.gastro.2007.01.051] [Cited by in Crossref: 238] [Cited by in F6Publishing: 240] [Article Influence: 15.9] [Reference Citation Analysis]
127 Silva MA. Intestinal dendritic cells and epithelial barrier dysfunction in Crohn’s disease. Inflamm Bowel Dis. 2009;15:436-453. [PMID: 18821596 DOI: 10.1002/ibd.20660] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
128 Vanuytsel T, Vermeire S, Cleynen I. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers. 2013;1:e27321. [PMID: 24868498 DOI: 10.4161/tisb.27321] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 7.2] [Reference Citation Analysis]
129 Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, Karow ML, Ahrens R, Artis D, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rothenberg ME. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 2006;118:257-68. [PMID: 16815164 DOI: 10.1016/j.jaci.2006.04.039] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 6.7] [Reference Citation Analysis]
130 Srivastava A, Gupta J, Kumar S, Kumar A. Gut biofilm forming bacteria in inflammatory bowel disease. Microb Pathog. 2017;112:5-14. [PMID: 28942174 DOI: 10.1016/j.micpath.2017.09.041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
131 Pashenkov MV, Dagil YA, Pinegin BV. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases. Int Immunopharmacol 2018;54:385-400. [PMID: 29207344 DOI: 10.1016/j.intimp.2017.11.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
132 Baumgart DC, Sandborn WJ. Crohn's disease. The Lancet 2012;380:1590-605. [DOI: 10.1016/s0140-6736(12)60026-9] [Cited by in Crossref: 1109] [Cited by in F6Publishing: 536] [Article Influence: 110.9] [Reference Citation Analysis]
133 Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology (Oxford) 2008;47:1223-7. [PMID: 18540025 DOI: 10.1093/rheumatology/ken140] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
134 Brandner JM, Schulzke JD. Hereditary barrier-related diseases involving the tight junction: lessons from skin and intestine. Cell Tissue Res 2015;360:723-48. [DOI: 10.1007/s00441-014-2096-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
135 Tang Y, Forsyth CB, Keshavarzian A. New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol 2011;5:615-25. [PMID: 21910579 DOI: 10.1586/egh.11.64] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
136 Jiang Y, Guo C, Zhang D, Zhang J, Wang X, Geng C. The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer. J Interferon Cytokine Res 2014;34:518-25. [PMID: 24720758 DOI: 10.1089/jir.2013.0020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
137 Valentini L, Eggers J, Ockenga J, Haas VK, Bühner S, Winklhofer-roob BM, Hengstermann S, Sinn B, Weigel A, Norman K, Pirlich M, Lochs H. Association between intestinal tight junction permeability and whole-body electrical resistance in healthy individuals: A hypothesis. Nutrition 2009;25:706-14. [DOI: 10.1016/j.nut.2008.11.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
138 Neunlist M, Van Landeghem L, Mahé MM, Derkinderen P, des Varannes SB, Rolli-Derkinderen M. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:90-100. [PMID: 23165236 DOI: 10.1038/nrgastro.2012.221] [Cited by in Crossref: 151] [Cited by in F6Publishing: 145] [Article Influence: 15.1] [Reference Citation Analysis]
139 Norén E, Almer S, Söderman J. Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease. BMC Gastroenterol 2017;17:68. [PMID: 28545409 DOI: 10.1186/s12876-017-0620-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
140 D'Incà R, Annese V, di Leo V, Latiano A, Quaino V, Abazia C, Vettorato MG, Sturniolo GC. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1455-1461. [PMID: 16669960 DOI: 10.1111/j.1365-2036.2006.02916.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 4.1] [Reference Citation Analysis]
141 Shashikanth N, Yeruva S, Ong MLDM, Odenwald MA, Pavlyuk R, Turner JR. Epithelial Organization: The Gut and Beyond. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1497-518. [DOI: 10.1002/cphy.c170003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
142 Camus M, Esses S, Pariente B, Le Bourhis L, Douay C, Chardiny V, Mocan I, Benlagha K, Clave E, Toubert A, Mayer L, Allez M. Oligoclonal expansions of mucosal T cells in Crohn’s disease predominate in NKG2D-expressing CD4 T cells. Mucosal Immunol 2014;7:325-34. [DOI: 10.1038/mi.2013.51] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
143 Sato K, Meng F, Fava G, Glaser S, Alpini G. Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 2019;3:40-5. [DOI: 10.1016/j.livres.2018.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
144 Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520. [PMID: 16966705 DOI: 10.1136/gut.2005.085373] [Cited by in Crossref: 358] [Cited by in F6Publishing: 350] [Article Influence: 25.6] [Reference Citation Analysis]
145 Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem. 2010;285:12037-12046. [PMID: 20177070 DOI: 10.1074/jbc.m109.064808] [Cited by in Crossref: 174] [Cited by in F6Publishing: 126] [Article Influence: 14.5] [Reference Citation Analysis]
146 Tabibian JH, Talwalkar JA, Lindor KD. Role of the microbiota and antibiotics in primary sclerosing cholangitis. Biomed Res Int 2013;2013:389537. [PMID: 24232746 DOI: 10.1155/2013/389537] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
147 Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, Herrmann K, Hofbauer K, Dambacher J, Tillack C, Sackmann M. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn’s disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol. 2006;41:1421-1432. [PMID: 17101573 DOI: 10.1080/00365520600703900] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
148 Ahrens B, Quarcoo D, Buhner S, Matricardi PM, Hamelmann E. Oral Administration of Bacterial Lysates Attenuates Experimental Food Allergy. Int Arch Allergy Immunol 2011;156:196-204. [DOI: 10.1159/000322352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
149 Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009;124:3-20; quiz 21-2. [PMID: 19560575 DOI: 10.1016/j.jaci.2009.05.038] [Cited by in Crossref: 794] [Cited by in F6Publishing: 748] [Article Influence: 61.1] [Reference Citation Analysis]
150 Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799-809. [PMID: 19855405 DOI: 10.1038/nri2653] [Cited by in Crossref: 1775] [Cited by in F6Publishing: 1702] [Article Influence: 136.5] [Reference Citation Analysis]
151 Graham WV, Marchiando AM, Shen L, Turner JR. No static at all. Ann N Y Acad Sci 2009;1165:314-22. [PMID: 19538322 DOI: 10.1111/j.1749-6632.2009.04050.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
152 Menchén L. [Cellular and molecular bases of intestinal barrier dysfunction induced by experimental stress]. Gastroenterol Hepatol 2009;32 Suppl 2:55-61. [PMID: 19900630 DOI: 10.1016/S0210-5705(09)72607-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Nighot P, Ma T. Role of autophagy in the regulation of epithelial cell junctions. Tissue Barriers 2016;4:e1171284. [PMID: 27583189 DOI: 10.1080/21688370.2016.1171284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
154 Sturgeon C, Lan J, Fasano A. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci 2017;1397:130-42. [PMID: 28423466 DOI: 10.1111/nyas.13343] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
155 Park JH, Peyrin-Biroulet L, Eisenhut M, Shin JI. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. Autoimmun Rev. 2017;16:416-426. [PMID: 28212924 DOI: 10.1016/j.autrev.2017.02.013] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 24.2] [Reference Citation Analysis]
156 Choi W, Yeruva S, Turner JR. Contributions of intestinal epithelial barriers to health and disease. Exp Cell Res 2017;358:71-7. [PMID: 28342899 DOI: 10.1016/j.yexcr.2017.03.036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
157 Haas V, Büning C, Buhner S, von Heymann C, Valentini L, Lochs H. Clinical relevance of measuring colonic permeability. Eur J Clin Invest. 2009;39:139-144. [PMID: 19200167 DOI: 10.1111/j.1365-2362.2008.02075.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
158 van der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, de Rooij FW. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. Eur J Gastroenterol Hepatol. 2007;19:449-459. [PMID: 17489054 DOI: 10.1097/01.meg.0000236887.44214.6a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
159 Edelblum KL, Sharon G, Singh G, Odenwald MA, Sailer A, Cao S, Ravens S, Thomsen I, El Bissati K, McLeod R, Dong C, Gurbuxani S, Prinz I, Mazmanian SK, Turner JR. The Microbiome Activates CD4 T-cell-mediated Immunity to Compensate for Increased Intestinal Permeability. Cell Mol Gastroenterol Hepatol. 2017;4:285-297. [PMID: 28795125 DOI: 10.1016/j.jcmgh.2017.06.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
160 Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, Fu YX, Turner JR. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology. 2007;132:2383-2394. [PMID: 17570213 DOI: 10.1053/j.gastro.2007.02.052] [Cited by in Crossref: 119] [Cited by in F6Publishing: 123] [Article Influence: 7.9] [Reference Citation Analysis]
161 Cai J, Chen H, Weng M, Jiang S, Gao J. Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn's Disease. Gastroenterol Res Pract 2019;2019:8536952. [PMID: 31531016 DOI: 10.1155/2019/8536952] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
162 He JS, Tan JY, Li XZ, Feng R, Xiong SS, Lin SN, Qiu Y, Mao R. Serum biomarkers of fibrostenotic Crohn's disease: Where are we now? J Dig Dis 2020;21:336-41. [PMID: 32496631 DOI: 10.1111/1751-2980.12913] [Reference Citation Analysis]
163 Waldner MJ, Neurath MF. Mechanisms of Immune Signaling in Colitis-Associated Cancer. Cell Mol Gastroenterol Hepatol 2015;1:6-16. [PMID: 28247866 DOI: 10.1016/j.jcmgh.2014.11.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
164 Ohlsson L, Gustafsson A, Lavant E, Suneson K, Brundin L, Westrin Å, Ljunggren L, Lindqvist D. Leaky gut biomarkers in depression and suicidal behavior. Acta Psychiatr Scand 2019;139:185-93. [PMID: 30347427 DOI: 10.1111/acps.12978] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
165 Kutikhin AG. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Hum Immunol. 2011;72:955-968. [PMID: 21745515 DOI: 10.1016/j.humimm.2011.06.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
166 Münch A, Ström M, Söderholm JD. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies. Scandinavian Journal of Gastroenterology 2009;42:1167-74. [DOI: 10.1080/00365520701320463] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
167 Valentini L, Ramminger S, Haas V, Postrach E, Werich M, Fischer A, Koller M, Swidsinski A, Bereswill S, Lochs H, Schulzke J. Small intestinal permeability in older adults. Physiol Rep 2014;2:e00281. [DOI: 10.1002/phy2.281] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
168 Van Limbergen J, Russell RK, Nimmo ER, Ho GT, Arnott ID, Wilson DC, Satsangi J. Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:338-55. [PMID: 17206667 DOI: 10.1002/ibd.20096] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
169 Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol. 2013;4:280. [PMID: 24062746 DOI: 10.3389/fimmu.2013.00280] [Cited by in Crossref: 245] [Cited by in F6Publishing: 237] [Article Influence: 27.2] [Reference Citation Analysis]
170 Mogilevski T, Burgell R, Aziz Q, Gibson PR. Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD. Aliment Pharmacol Ther 2019;50:720-37. [DOI: 10.1111/apt.15433] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
171 Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci. 2012;1258:9-18. [PMID: 22731710 DOI: 10.1111/j.1749-6632.2012.06613.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 11.7] [Reference Citation Analysis]
172 McGilligan VE, Wallace JM, Heavey PM, Ridley DL, Rowland IR. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis 2007;13:108-15. [PMID: 17206646 DOI: 10.1002/ibd.20020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
173 Blonski W, Buchner AM, Aberra F, Lichtenstein G. Teduglutide in Crohn's disease. Expert Opinion on Biological Therapy 2013;13:1207-14. [DOI: 10.1517/14712598.2013.815721] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
174 Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640. [PMID: 17499605 DOI: 10.1016/s0140-6736(07)60750-8] [Cited by in Crossref: 1094] [Cited by in F6Publishing: 505] [Article Influence: 72.9] [Reference Citation Analysis]
175 Jürgens M, Brand S, Laubender RP, Seiderer J, Glas J, Wetzke M, Wagner J, Pfennig S, Tillack C, Beigel F. The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype. J Gastroenterol. 2010;45:721-731. [PMID: 20428899 DOI: 10.1007/s00535-010-0231-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
176 Söderman J, Norén E, Christiansson M, Bragde H, Thiébaut R, Hugot JP, Tysk C, O’Morain CA, Gassull M, Finkel Y, Colombel JF, Lémann M, Almer S. Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease. World J Gastroenterol 2013; 19(30): 4935-4943 [PMID: 23946598 DOI: 10.3748/wjg.v19.i30.4935] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
177 Sidiq T, Yoshihama S, Downs I, Kobayashi KS. Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease. Front Immunol. 2016;7:367. [PMID: 27703457 DOI: 10.3389/fimmu.2016.00367] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
178 Keita AV, Salim SY, Jiang T, Yang PC, Franzén L, Söderkvist P, Magnusson KE, Söderholm JD. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn’s disease. J Pathol. 2008;215:135-144. [PMID: 18348161 DOI: 10.1002/path.2337] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
179 de Magistris L, Picardi A, Sapone A, Cariello R, Siniscalco D, Bravaccio C, Pascotto A. Intestinal Barrier in Autism. In: Patel VB, Preedy VR, Martin CR, editors. Comprehensive Guide to Autism. New York: Springer; 2014. pp. 2047-60. [DOI: 10.1007/978-1-4614-4788-7_123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Pellino G, Pallante P, Selvaggi F. Novel biomarkers of fibrosis in Crohn’s disease. World J Gastrointest Pathophysiol 2016; 7(3): 266-275 [PMID: 27574564 DOI: 10.4291/wjgp.v7.i3.266] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
181 Ruiz Castro PA, Yepiskoposyan H, Gubian S, Calvino-Martin F, Kogel U, Renggli K, Peitsch MC, Hoeng J, Talikka M. Systems biology approach highlights mechanistic differences between Crohn's disease and ulcerative colitis. Sci Rep 2021;11:11519. [PMID: 34075172 DOI: 10.1038/s41598-021-91124-3] [Reference Citation Analysis]
182 Buttó LF, Schaubeck M, Haller D. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol 2015;6:555. [PMID: 26635787 DOI: 10.3389/fimmu.2015.00555] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
183 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Reference Citation Analysis]
184 Mao JW, Wang YD. Advances in understanding the pathogenesis of mucosal barrier dysfunction in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2010; 18(7): 695-698 [DOI: 10.11569/wcjd.v18.i7.695] [Reference Citation Analysis]
185 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Hollander D, Kaunitz JD. The "Leaky Gut": Tight Junctions but Loose Associations? Dig Dis Sci 2020;65:1277-87. [PMID: 31471860 DOI: 10.1007/s10620-019-05777-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
187 Ahmad R, Sorrell MF, Batra SK, Dhawan P, Singh AB. Gut permeability and mucosal inflammation: bad, good or context dependent. Mucosal Immunol 2017;10:307-17. [PMID: 28120842 DOI: 10.1038/mi.2016.128] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 16.2] [Reference Citation Analysis]
188 Nalle SC, Turner JR. Endothelial and epithelial barriers in graft-versus-host disease. Adv Exp Med Biol 2012;763:105-31. [PMID: 23397621 DOI: 10.1007/978-1-4614-4711-5_5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
189 Willing B, Halfvarson J, Dicksved J, Rosenquist M, Järnerot G, Engstrand L, Tysk C, Jansson JK. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm Bowel Dis. 2009;15:653-660. [PMID: 19023901 DOI: 10.1002/ibd.20783] [Cited by in Crossref: 323] [Cited by in F6Publishing: 314] [Article Influence: 24.8] [Reference Citation Analysis]
190 Schwarzer R, Jiao H, Wachsmuth L, Tresch A, Pasparakis M. FADD and Caspase-8 Regulate Gut Homeostasis and Inflammation by Controlling MLKL- and GSDMD-Mediated Death of Intestinal Epithelial Cells. Immunity 2020;52:978-993.e6. [PMID: 32362323 DOI: 10.1016/j.immuni.2020.04.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
191 Al Nabhani Z, Montcuquet N, Roy M, Dussaillant M, Hugot J, Barreau F. Complementary Roles of Nod2 in Hematopoietic and Nonhematopoietic Cells in Preventing Gut Barrier Dysfunction Dependent on MLCK Activity: . Inflammatory Bowel Diseases 2017;23:1109-19. [DOI: 10.1097/mib.0000000000001135] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
192 Alonso C, Vicario M, Pigrau M, Lobo B, Santos J. Intestinal barrier function and the brain-gut axis. Adv Exp Med Biol. 2014;817:73-113. [PMID: 24997030 DOI: 10.1007/978-1-4939-0897-4_4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
193 Tabibian JH, O'Hara SP, Lindor KD. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scand J Gastroenterol 2014;49:901-8. [PMID: 24990660 DOI: 10.3109/00365521.2014.913189] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
194 Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, Harsfalvi J, Papp J, Papp M. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. Inflamm Bowel Dis. 2011;17:767-777. [PMID: 20865702 DOI: 10.1002/ibd.21402] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
195 Büning C, Durmus T, Molnar T, de Jong DJ, Drenth JP, Fiedler T, Gentz E, Todorov T, Haas V, Buhner S. A study in three European IBD cohorts confirms that the ATG16L1 c.898A& gt; G (p.Thr300Ala) variant is a susceptibility factor for Crohn’s disease. J Crohns Colitis. 2007;1:70-76. [PMID: 21172187 DOI: 10.1016/j.crohns.2007.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
196 Goethel A, Croitoru K, Philpott DJ. The interplay between microbes and the immune response in inflammatory bowel disease. J Physiol. 2018;596:3869-3882. [PMID: 29806140 DOI: 10.1113/jp275396] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
197 France MM, Turner JR. The mucosal barrier at a glance. J Cell Sci 2017;130:307-14. [PMID: 28062847 DOI: 10.1242/jcs.193482] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 19.6] [Reference Citation Analysis]
198 Núñez C, Oliver J, Mendoza JL, Gómez-García M, Piñero A, Taxonera C, Díaz-Rubio M, López-Nevot MA, de la Concha EG, Nieto A, Urcelay E, Martínez A, Martín J. MYO9B polymorphisms in patients with inflammatory bowel disease. Gut 2007;56:1321-2. [PMID: 17698871 DOI: 10.1136/gut.2007.121905] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
199 Mayor NP, Shaw BE, Madrigal JA, Marsh SG. NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome. Bone Marrow Res 2012;2012:180391. [PMID: 23119165 DOI: 10.1155/2012/180391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
200 Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Review of Molecular Diagnostics 2014;6:345-63. [DOI: 10.1586/14737159.6.3.345] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
201 Graham WV, He W, Marchiando AM, Zha J, Singh G, Li HS, Biswas A, Ong MLDM, Jiang ZH, Choi W, Zuccola H, Wang Y, Griffith J, Wu J, Rosenberg HJ, Snapper SB, Ostrov D, Meredith SC, Miller LW, Turner JR. Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis.Nat Med. 2019;25:690-700. [PMID: 30936544 DOI: 10.1038/s41591-019-0393-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
202 de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13-27. [PMID: 26627550 DOI: 10.1038/nrgastro.2015.186] [Cited by in Crossref: 612] [Cited by in F6Publishing: 575] [Article Influence: 87.4] [Reference Citation Analysis]
203 Natividad JM, Petit V, Huang X, de Palma G, Jury J, Sanz Y, Philpott D, Garcia Rodenas CL, McCoy KD, Verdu EF. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. Inflamm Bowel Dis. 2012;18:1434-1446. [PMID: 22162005 DOI: 10.1002/ibd.22848] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 8.0] [Reference Citation Analysis]
204 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:718356. [PMID: 34589512 DOI: 10.3389/fnut.2021.718356] [Reference Citation Analysis]
205 Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14:9-21. [PMID: 27848962 DOI: 10.1038/nrgastro.2016.169] [Cited by in Crossref: 324] [Cited by in F6Publishing: 329] [Article Influence: 54.0] [Reference Citation Analysis]
206 Murdoch TB, Xu W, Stempak JM, Landers C, Targan SR, Rotter JI, Silverberg MS. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease. Inflamm Bowel Dis 2012;18:1743-8. [PMID: 22275320 DOI: 10.1002/ibd.22884] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
207 Dorshow RB, Johnson JR, Debreczeny MP, Riley IR, Shieh JJ, Rogers TE, Hall-Moore C, Shaikh N, Rouggly-Nickless LC, Tarr PI. Transdermal fluorescence detection of a dual fluorophore system for noninvasive point-of-care gastrointestinal permeability measurement. Biomed Opt Express 2019;10:5103-16. [PMID: 31646033 DOI: 10.1364/BOE.10.005103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
208 Neunlist M, Van Landeghem L, Bourreille A, Savidge T. Neuro-glial crosstalk in inflammatory bowel disease. J Intern Med. 2008;263:577-583. [PMID: 18479256 DOI: 10.1111/j.1365-2796.2008.01963.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
209 Chen L, Wang J, You Q, He S, Meng Q, Gao J, Wu X, Shen Y, Sun Y, Wu X, Xu Q. Activating AMPK to Restore Tight Junction Assembly in Intestinal Epithelium and to Attenuate Experimental Colitis by Metformin. Front Pharmacol. 2018;9:761. [PMID: 30061832 DOI: 10.3389/fphar.2018.00761] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
210 Turpin W, Lee SH, Raygoza Garay JA, Madsen KL, Meddings JB, Bedrani L, Power N, Espin-Garcia O, Xu W, Smith MI, Griffiths AM, Moayyedi P, Turner D, Seidman EG, Steinhart AH, Marshall JK, Jacobson K, Mack D, Huynh H, Bernstein CN, Paterson AD, Croitoru K; Crohn’s and Colitis Canada Genetic Environmental Microbial Project Research Consortium., CCC GEM Project recruitment site directors include Maria Abreu. Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease. Gastroenterology 2020;159:2092-2100.e5. [PMID: 32791132 DOI: 10.1053/j.gastro.2020.08.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
211 Bullen TF, Forrest S, Campbell F, Dodson AR, Hershman MJ, Pritchard DM, Turner JR, Montrose MH, Watson AJ. Characterization of epithelial cell shedding from human small intestine. Lab Invest. 2006;86:1052-1063. [PMID: 16909128 DOI: 10.1038/labinvest.3700464] [Cited by in Crossref: 133] [Cited by in F6Publishing: 120] [Article Influence: 8.3] [Reference Citation Analysis]
212 Luettig J, Rosenthal R, Barmeyer C, Schulzke JD. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation. Tissue Barriers 2015;3:e977176. [PMID: 25838982 DOI: 10.4161/21688370.2014.977176] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 15.7] [Reference Citation Analysis]
213 Berglund M, Melgar S, Kobayashi KS, Flavell RA, Hörnquist EH, Hultgren OH. IL-1 receptor-associated kinase M downregulates DSS-induced colitis. Inflamm Bowel Dis. 2010;16:1778-1786. [PMID: 20848470 DOI: 10.1002/ibd.21287] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
214 Malíčková K, Francová I, Lukáš M, Kolář M, Králíková E, Bortlík M, Ďuricová D, Štěpánková L, Zvolská K, Pánková A, Zima T. Fecal zonulin is elevated in Crohn's disease and in cigarette smokers. Pract Lab Med 2017;9:39-44. [PMID: 29034305 DOI: 10.1016/j.plabm.2017.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
215 Nighot PK, Hu CA, Ma TY. Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation. J Biol Chem 2015;290:7234-46. [PMID: 25616664 DOI: 10.1074/jbc.M114.597492] [Cited by in Crossref: 87] [Cited by in F6Publishing: 55] [Article Influence: 12.4] [Reference Citation Analysis]
216 Øyri SF, Műzes G, Sipos F. Dysbiotic gut microbiome: A key element of Crohn's disease. Comp Immunol Microbiol Infect Dis 2015;43:36-49. [PMID: 26616659 DOI: 10.1016/j.cimid.2015.10.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
217 Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci. 2006;1072:242-252. [PMID: 17057204 DOI: 10.1196/annals.1326.017] [Cited by in Crossref: 136] [Cited by in F6Publishing: 134] [Article Influence: 8.5] [Reference Citation Analysis]
218 Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Stagg AJ, Lindsay JO, Whelan K. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease. Clin Nutr 2021;40:5009-19. [PMID: 34364241 DOI: 10.1016/j.clnu.2021.05.033] [Reference Citation Analysis]
219 Camilleri M. What is the leaky gut? Clinical considerations in humans. Curr Opin Clin Nutr Metab Care 2021;24:473-82. [PMID: 34138767 DOI: 10.1097/MCO.0000000000000778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Kaunitz JD. Introduction to the "paradigm shifts in perspective" series. Dig Dis Sci 2013;58:1825-6. [PMID: 23756736 DOI: 10.1007/s10620-013-2729-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
221 Ozaka S, Sonoda A, Ariki S, Kamiyama N, Hidano S, Sachi N, Ito K, Kudo Y, Minata M, Saechue B, Dewayani A, Chalalai T, Soga Y, Takahashi Y, Fukuda C, Mizukami K, Okumura R, Kayama H, Murakami K, Takeda K, Kobayashi T. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier. Genes Cells 2021. [PMID: 34379860 DOI: 10.1111/gtc.12888] [Reference Citation Analysis]
222 Prager M, Büttner J, Haas V, Baumgart DC, Sturm A, Zeitz M, Büning C. The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action. Int J Colorectal Dis 2012;27:565-73. [PMID: 22065112 DOI: 10.1007/s00384-011-1345-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
223 Tanaka H, Takechi M, Kiyonari H, Shioi G, Tamura A, Tsukita S. Intestinal deletion of Claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice. Gut. 2015;64:1529-1538. [PMID: 25691495 DOI: 10.1136/gutjnl-2014-308419] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 13.3] [Reference Citation Analysis]
224 Yu YB, Li YQ. Enteric glial cells and their role in the intestinal epithelial barrier. World J Gastroenterol 2014; 20(32): 11273-11280 [PMID: 25170211 DOI: 10.3748/wjg.v20.i32.11273] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
225 Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML. Seroreactivity to microbial components in Crohn’s disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis. 2007;13:984-992. [PMID: 17417801 DOI: 10.1002/ibd.20146] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 3.5] [Reference Citation Analysis]
226 Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut 2018;67:1726-38. [DOI: 10.1136/gutjnl-2017-315866] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 25.3] [Reference Citation Analysis]
227 Cirillo C, Sarnelli G, Esposito G, Grosso M, Petruzzelli R, Izzo P, Calì G, D’Armiento FP, Rocco A, Nardone G. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Neurogastroenterol Motil. 2009;21:1209-e112. [PMID: 19558426 DOI: 10.1111/j.1365-2982.2009.01346.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
228 Teshima CW, Dieleman LA, Meddings JB. Abnormal intestinal permeability in Crohn’s disease pathogenesis. Ann N Y Acad Sci. 2012;1258:159-165. [PMID: 22731729 DOI: 10.1111/j.1749-6632.2012.06612.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
229 Bakirtzi K, Hoffman JM, Pothoulakis C. Silence Please!: siRNA approaches to tighten the intestinal barrier in vivo. Am J Pathol 2013;183:1700-2. [PMID: 24183845 DOI: 10.1016/j.ajpath.2013.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
230 Ma Y, Yin Z, Li L, Chen B, Dai H, Wu D, Cong J, Ye L, Liao C, Li L, Ye Z, Huang Z. Food antigens exacerbate intestinal damage and inflammation following the disruption of the mucosal barrier. Int Immunopharmacol 2021;96:107670. [PMID: 33984722 DOI: 10.1016/j.intimp.2021.107670] [Reference Citation Analysis]
231 Chan D, Kumar D, Mendall M. What is known about the mechanisms of dietary influences in Crohn's disease? Nutrition 2015;31:1195-203. [PMID: 26333887 DOI: 10.1016/j.nut.2015.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]